优化mRNA载脂纳米粒子作为蛋白替代疗法的潜在工具
Rocío Gambaro1, Ignacio Rivero Berti1,2, María José Limeres1
1Children's Hospital, University Medical Center of the Johannes, Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Pharmaceutics
|June 27, 2024
概括
研究人员优化了脂质纳米粒子 (LNP) 进行mRNA输送,以治疗代谢疾病. 不同的脂质配方显示出不同的炎症反应和mRNA表达,这表明重复剂量可能会减少反应性载体.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
背景情况:
- 代谢性疾病需要有效的治疗策略.
- 脂质纳米颗粒 (LNP) 是mRNA传递的一个有前途的平台.
- 优化LNP配方对于治疗疗效和安全至关重要.
研究的目的:
- 为了优化脂质纳米粒子 (LNP) 配方用于mRNA输送.
- 为了评估不同脂质组成对LNP性能的影响.
- 评估LNP适用于治疗代谢性疾病的适用性,重点关注反应性和mRNA表达.
主要方法:
- 四种不同的脂质混合物 (LM1-LM4) 的配方,具有不同的脂质成分.
- 描述LNP的大小,稳定性和mRNA封装效率.
- 在体外评估mRNA输送到细胞系 (HepG2,DC2.4) 和PBMCs的细胞因子分泌.
- 在肌肉内注射后在小鼠体内生物分布研究.
主要成果:
- 临床核蛋白表现出稳定性,同质性 (75-90 nm) 和高mRNA封装 (95-100%).
- 在PBMC中,LM1,LM2和LM4诱导了显著的细胞因子分泌 (IL-8,TNF-α,MCP-1),而LM3显示了最小的诱导.
- 活体内研究显示,注射后肝脏中的初级mRNA表达.
- 配方修改影响了反应性,炎症反应和mRNA表达.
结论:
- 修改LNP组件会影响炎症反应和mRNA的表达.
- 特定的LNP配方显示出治疗代谢性疾病的潜力.
- 该研究提供了一个选择较少反应性载体的平台,用于在代谢性疾病治疗中重复剂量.
相关概念视频
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


